Composite Function Class 12

Genentech’s Fenebrutinib Significantly Reduced Relapses Versus Standard of Care to Approximately One Every 17 Years in RMS

Late-breaking Phase III FENhance 1 and 2 study results showed superiority of investigational fenebrutinib compared to teriflunomide in reducing relapses and brain lesions in relapsing multiple ...

This traveler has flown business class 521 times and counting. Here’s when he thinks it’s worth it — and when it’s not

Since 2010, frequent flyer Richard Robinson has logged 945 flights — 521 of those in business class. Here’s what he says ...

Communications of the ACM

In Memoriam: Michael O. Rabin

Theoretical ideas have a real-life impact,” said Michael Oser Rabin in a 2009 interview, 1 and he spent nearly seven decades ...

TMCnet

Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks

Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a late-stage clinical biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced positive ...

4don MSN

Do Bigger Planes Always Mean More Comfort?

New, smaller aircraft are able to compete with larger widebodies on comfort.

Lupus Science & Medicine

Effect of belimumab on patients with lupus nephritis and impaired kidney function: post hoc subgroup analysis of the phase III BLISS-LN trial

Lupus nephritis (LN) is one of the most serious complications of SLE, manifesting as haematuria and/or proteinuria, ...

Show inaccessible results

Genentech’s Fenebrutinib Significantly Reduced Relapses Versus Standard of Care to Approximately One Every 17 Years in RMS

This traveler has flown business class 521 times and counting. Here’s when he thinks it’s worth it — and when it’s not

In Memoriam: Michael O. Rabin

Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks

Do Bigger Planes Always Mean More Comfort?

Effect of belimumab on patients with lupus nephritis and impaired kidney function: post hoc subgroup analysis of the phase III BLISS-LN trial

HDFC Bank Limited (HDB) Q4 2026 Earnings Call Transcript

Unicycive Therapeutics, Inc. (UNCY) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript

Freetime: April 16

AI in the classroom sparks debate on the identity of a learner

Exhaustion and Endurance: Contrasting US–Russian Defence Industrial Resilience and Lessons for India